Chronic Lung Disease and Cystic Fibrosis Phenotype in Prolidase Deficiency: A Newly Recognized Association

Journal of Pediatrics

Volumn 150, Issue 6, 2007, Pages

  Luder, A S ^a,b   Mandel, H ^b,c   Khayat, M ^d   Gurevich, I ^d   Frankel, P ^d   Rivlin, J ^b,e   Falik Zaccai, T C ^d  

^a Rebecca Sieff Government Hospital   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

^d WESTERN GALILEE HOSPITAL   (Israel)

^e CARMEL MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROLINE DIPEPTIDASE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ARTICLE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CYSTIC FIBROSIS; ENZYME DEFICIENCY; FAMILY; HUMAN; INFANT; MALE; MUTATION; PHENOTYPE; PRIORITY JOURNAL;

EID: 34249018850     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.03.025     Document Type: Article

References (11)

1. Mandel H., Abeling A., Gutman A., Berant M., Scholten E.G., Sheiman C., et al. Prolidase deficiency among an Israeli population: prenatal diagnosis in a genetic disorder with uncertain prognosis. Prenat Diagn 20 (2000) 927-929
2. th ed (2001), McGraw-Hill, New York 1839-1853
3. Groman J.D., Meyer M.E., Wilmott R.W., Zeitlin P.L., and Cutting G.R. Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N Engl J Med 347 (2002) 401-407
4. National Institutes of Health consensus development conference statement on genetic testing for cystic fibrosis. Arch Intern Med 159 (1999) 1529-1539
5. Laufer-Cahana A., Lerer I., Sagi M., Rachmilewitz M.T., Zamir C., Rivlin J., et al. Cystic fibrosis mutations in Israeli-Arab patients. Hum Mutat 14 (1999) 543
6. Rosenbloom C.L., Kerem B.S., Rommens J.M., Tsui L.C., Wainwright B., Williamson R., et al. DNA amplification for detection of the XV-2c polymorphism linked to cystic fibrosis. Nucl Acids Res 17 (1989) 7117
7. Horn G.T., Richards B., Merrill J.J., and Klinger K.W. Characterization and rapid diagnostic analysis of DNA polymorphisms closely linked to the cystic fibrosis locus. Clin Chem 36 (1990) 1614-1619
8. Dork T., Neumann T., Wulbrand U., Wulf B., Kalin N., Maass G., et al. Intra- and extragenic marker haplotypes of CFTR mutations in cystic fibrosis families. Hum Genet 88 (1992) 417-425
9. Kerem B.S., Zielenski J., Markiewicz D., Bozon D., Gazit E., Yahav J., et al. Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci USA 87 (1990) 8447-8451
10. Wang H., Kurien B.T., Lundgren D., Patel N.C., Kaufman K.M., et al. A nonsense mutation of PEPD in four Amish children with prolidase deficiency. Am J Med Genet 140A (2006) 580-585
11. Groman J.D., Karczeski M., Sheridan M., Robinson T., Fallin M., et al. Phenotypic and genetic characterization of patients with features of "nonclassic" forms of cystic fibrosis. J Pediatr 146 (2005) 675-680